Sponsored Links
CORRECTED-U.S. FDA says Zithromax can cause fatal irregular heart rhythm
(Corrects spelling of "heart" in headline)
March 12 (Reuters) - The U.S. Food and Drug Administration on Tuesday said that the antibiotic azithromycin, sold as Zithromax or Zmax, can cause a potentially fatal irregular heart rhythm in some patients.
Earlier this year a New England Journal of Medicine study compared the risk of cardiovascular death from different antibacterial drugs and found that the drug, which is made by Pfizer Inc and is also sold by generic drugmakers, had a higher rate of death. (Reporting By Caroline Humer; Editing by Gerald E. McCormick)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (1)
JamesWilson wrote:
Finally they find this out? Zithromax has been on the market in the USA, and prescribed by doctors since 1986! This reminds me that it took 7 years before the FDA warned us that the class of anti-depressants; SSRI’s were potentially very dangerous to adolescents. This same research was well known and publicized in Europe long before the FDA decided to “Black Box” it and list the dangers. Had it not been for the work of Focus Adolescent Services I wonder how many children on those medications may have suicided. We can thank them for saving the lives of countless adolescents and even perhaps support their work.
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters